The therapeutic potential of microdosing psychedelics in depression
Microdosing psychedelics is the repeated use of small doses of, for example, lysergic acid diethylamide (LSD) and psilocybin, typically for a few weeks. Despite the popular and scientific attention in recent years, and claims by users that it has therapeutic value in affective disorders like depress...
Saved in:
Main Author: | Kim P.C. Kuypers (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychedelic microdosing benefits and challenges: an empirical codebook
by: Thomas Anderson, et al.
Published: (2019) -
Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube
by: Martin Andersson, et al.
Published: (2019) -
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
by: Daniel Meling, et al.
Published: (2024) -
Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders
by: Tamara Valdez, et al.
Published: (2024) -
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
by: Leor Roseman, et al.
Published: (2018)